BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistanceKsenija Nešić, Harold C. Sullivan, Pooja Patel et al.|Molecular Cancer|2024Cited by 28
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with EribulinGwo‐Yaw Ho, Holly E. Barker, Elizabeth L. Kyran et al.|Cancer Research|2022Cited by 26